Female Cialis
Female Cialis Price range: $ 20,00 through $ 340,00
Back to products
Female Viagra
Female Viagra Price range: $ 41,00 through $ 305,00

Female Cialis Soft

Price range: $ 40,00 through $ 288,00

Female Cialis Soft is a specialized formula designed to help women address symptoms of sexual arousal disorder and enhance intimate experiences. Each soft tablet contains Tadalafil, which works by increasing blood flow to the pelvic region to boost physical sensitivity. The quick-dissolving format allows the medication to enter the bloodstream faster, ensuring you are ready when the moment is right. Regular use can lead to improved natural lubrication and a more profound response to sexual stimulation. This effective treatment helps women regain their sexual confidence and enjoy a more fulfilling personal life.

Active substance: Tadalafil
SKU: Female Cialis Soft Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Female Cialis Soft belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors, containing the active substance tadalafil in a chewable or soft tablet formulation. The active ingredient is dispensed in accordance with applicable federal and state regulations within the United States.

While tadalafil is FDA-approved for specific indications in male patients–such as erectile dysfunction and benign prostatic hyperplasia–and for pulmonary arterial hypertension under distinct brand names, its formulation as Female Cialis Soft for female sexual arousal disorder represents an off-label and unapproved use. Patients evaluating this therapeutic agent should review its clinical properties, metabolic path, safety profile, and potential drug-drug interactions under licensed medical supervision.

Parameter Clinical Detail
Active ingredient (INN) Tadalafil
Therapeutic class Phosphodiesterase type 5 (PDE5) inhibitor
Dosage form Chewable / Soft oral tablet
Route of administration Oral
Primary clinical purpose Off-label investigation for pelvic blood flow enhancement
Prescription status Dispensed in accordance with applicable federal and state regulations

Pharmacological Profile and Off-Label Indications

How the drug works

The active constituent, tadalafil, operates via competitive inhibition of the PDE5 enzyme. PDE5 is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in smooth muscle cells surrounding vascular beds. By inhibiting PDE5 activity, tadalafil prevents the breakdown of cGMP, leading to prolonged vascular smooth muscle relaxation and enhanced nitric oxide-mediated vasodilation. In pelvic tissues, this cascade increases localized arterial inflow and vascular engorgement. However, the physiological mechanisms governing female sexual arousal involve complex neuroendocrine pathways that extend beyond isolated peripheral vasodilation.

Main uses and off-label status

Female Cialis Soft is designated for the off-label management of female sexual arousal disorder (FSAD) and related vascular dynamics in female patients. It is vital to state that the United States Food and Drug Administration (FDA) has not approved tadalafil under the product name Female Cialis Soft for female sexual dysfunction. Clinical evidence regarding efficacy in women remains variable, and prescribing this medication for non-approved conditions occurs entirely off-label at the discretion of a qualified healthcare provider.

How it is absorbed and eliminated

Following oral administration of tadalafil, peak plasma concentrations (Cmax) are typically achieved between 30 minutes and 6 hours, with a median time (Tmax) of approximately 2 hours in the fasting state. The absolute bioavailability of the chewable tablet form has not been fully characterized in separate public FDA registration files compared to standard oral tablets. Tadalafil exhibits extensive tissue distribution and is approximately 94% bound to plasma proteins. Metabolism occurs predominantly in the liver via the cytochrome P450 3A4 (CYP3A4) enzyme pathway. The mean terminal elimination half-life is approximately 17.5 hours in healthy adult individuals, with metabolites excreted primarily through feces (roughly 61%) and to a lesser extent in urine (roughly 36%).

Dosing Schedule and Administration

Because Female Cialis Soft is an off-label formulation, standardized FDA dosing schedules for female sexual dysfunction do not exist. In clinical discussions, dosing is determined individually by a licensed prescriber based on patient tolerability, hepatic function, and renal health. The chewable tablet is administered orally prior to anticipated sexual activity. Patients must not exceed one dose within a 24-hour period due to the prolonged half-life of tadalafil. Dose adjustments are required for individuals with mild to moderate renal impairment or hepatic insufficiency, whereas use in severe renal failure or end-stage liver disease is generally not recommended.

Safety Profile and Clinical Management

Compatibility with other medicines

Co-administration of tadalafil with organic nitrates in any form–including nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, or recreational “poppers” (alkyl nitrites)–is strictly contraindicated. Simultaneous use can trigger acute, life-threatening potentiation of hypotensive effects. Caution is required when combined with alpha-adrenergic blockers (such as tamsulosin or doxazosin), as concomitant administration may cause symptomatic orthostatic hypotension. Concomitant use of potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir) significantly increases systemic tadalafil exposure, necessitating lower initial doses. Conversely, strong CYP3A4 inducers (such as rifampin, carbamazepine, or St. John’s wort) can lower plasma concentrations and reduce overall efficacy.

Adverse reactions

Systemic administration of PDE5 inhibitors can lead to systemic adverse events related to smooth muscle relaxation. Common side effects reported with tadalafil include headache, dyspepsia (indigestion), facial flushing, nasopharyngitis, back pain, and myalgia. Back pain and myalgia typically occur 12 to 24 hours post-dose and usually resolve within 48 hours. Rare but severe adverse reactions include sudden decrease or loss of vision attributed to non-arteritic anterior ischemic optic neuropathy (NAION) and sudden decrease or loss of hearing, occasionally accompanied by tinnitus and dizziness. Patients experiencing visual or auditory disturbances should immediately discontinue the medication.

Important Precautions and Special Populations

Prior to initiating treatment with tadalafil, a comprehensive cardiovascular evaluation is necessary, as sexual activity carries an inherent cardiac risk for individuals with pre-existing heart conditions. Patients with unstable angina, recent myocardial infarction, severe heart failure, unmanaged arrhythmias, or severe uncontrolled hypertension should avoid use. Regarding specific populations: safety and efficacy have not been formally established in pediatric populations; use during pregnancy or lactation should occur strictly under medical direction after assessing potential risk-benefit ratios; and elderly patients may demonstrate reduced clearance, warranting careful dose selection.

Red Flags and Emergency Steps

Immediate emergency medical care must be sought if any of the following serious symptoms occur following administration:

  • Chest pain, pressure, or an irregular heartbeat during or after activity
  • Signs of a severe hypersensitivity reaction, such as swelling of the face, lips, tongue, or throat
  • Difficulty breathing or severe shortness of breath
  • Sudden visual impairment, partial vision loss, or sudden alteration in color perception
  • Sudden reduction or complete loss of hearing
  • Severe dizziness, fainting (syncope), or marked drop in blood pressure

First Days of Treatment and Expectations

Patients beginning an off-label regimen should recognize that PDE5 inhibitors do not act as direct aphrodisiacs; biological or sensory stimulation remains essential to initiate physiological vasodilation. During initial administration, patients may notice transient flushing or mild headaches as systemic blood vessels adapt to PDE5 inhibition. Dosing should not be altered independently if immediate results are not observed, nor should multiple doses be taken concurrently to accelerate therapeutic onset.

Food and alcohol interactions

Tadalafil absorption is not significantly affected by food, meaning tablets may be taken with or without meals. However, excessive consumption of ethanol (alcohol) in combination with tadalafil increases the risk of orthostatic signs and symptoms, including increased heart rate, decreased standing blood pressure, dizziness, and headache. Patients are advised to avoid heavy alcohol intake while using PDE5 inhibitors.

Storage and expiration

Female Cialis Soft tablets should be stored at controlled room temperature, ideally between 20°C and 25°C (68°F to 77°F), with temporary excursions permitted between 15°C and 30°C (59°F to 86°F). Keep the medication in its original packaging to protect the chewable tablets from excessive moisture and direct light. Store securely out of reach of children and pets. Do not use tablets past the expiration date printed on the packaging, and dispose of unused medication according to local pharmacy take-back guidelines.

Common Questions

Is Female Cialis Soft approved by the FDA for female sexual dysfunction?

No. The specific trade formulation known as Female Cialis Soft is not FDA-approved. Tadalafil is FDA-approved for male erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. Any administration in female patients for sexual arousal disorder is strictly an off-label medical practice.

What occurs if nitrates are taken simultaneously with tadalafil?

Combining tadalafil with organic nitrates causes an additive, unpredictable dilation of blood vessels. This interaction can lead to a severe, dangerous fall in blood pressure (hypotension), potentially resulting in syncope, myocardial ischemia, or cerebrovascular events. Nitrates in any form must be completely avoided.

Does food alter how the soft tablet is absorbed?

Unlike some other PDE5 inhibitors, the rate and extent of tadalafil absorption are not meaningfully altered by food intake. The chewable tablet may be taken with or without food, though high-fat meals might subtly delay initial systemic absorption depending on individual digestive rates.

How long does tadalafil remain active in the systemic circulation?

Tadalafil possesses a prolonged terminal elimination half-life of approximately 17.5 hours. As a result, circulating drug levels remain active in the body for up to 36 hours post-administration. This extended duration mandates strict adherence to once-daily maximum dosing limits.

What step should be taken if a severe headache develops after administration?

Headache is a recognized side effect due to cranial vasodilation. If a persistent or severe headache develops, contact a healthcare provider for advice. Patients should not take additional doses and must refrain from taking unauthorized over-the-counter pain medications if contraindicated by other health conditions.

This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.

Additional information
Dosage

10mg

Package

10 pills

,

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία